151 related articles for article (PubMed ID: 11068194)
1. A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia.
Verhoeff NP; Meyer JH; Kecojevic A; Hussey D; Lewis R; Tauscher J; Zipursky RB; Kapur S
Psychiatry Res; 2000 Oct; 99(3):123-35. PubMed ID: 11068194
[TBL] [Abstract][Full Text] [Related]
2. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone.
Ngan ET; Yatham LN; Ruth TJ; Liddle PF
Am J Psychiatry; 2000 Jun; 157(6):1016-8. PubMed ID: 10831488
[TBL] [Abstract][Full Text] [Related]
3. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
[TBL] [Abstract][Full Text] [Related]
4. Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.
Tauscher J; Kapur S; Verhoeff NP; Hussey DF; Daskalakis ZJ; Tauscher-Wisniewski S; Wilson AA; Houle S; Kasper S; Zipursky RB
Arch Gen Psychiatry; 2002 Jun; 59(6):514-20. PubMed ID: 12044193
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2A receptor density is decreased in the at-risk mental state.
Hurlemann R; Matusch A; Kuhn KU; Berning J; Elmenhorst D; Winz O; Kolsch H; Zilles K; Wagner M; Maier W; Bauer A
Psychopharmacology (Berl); 2008 Jan; 195(4):579-90. PubMed ID: 17899021
[TBL] [Abstract][Full Text] [Related]
6. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study.
Meyer JH; Kapur S; Eisfeld B; Brown GM; Houle S; DaSilva J; Wilson AA; Rafi-Tari S; Mayberg HS; Kennedy SH
Am J Psychiatry; 2001 Jan; 158(1):78-85. PubMed ID: 11136637
[TBL] [Abstract][Full Text] [Related]
7. Brain serotonin2 receptors in major depression: a positron emission tomography study.
Yatham LN; Liddle PF; Shiah IS; Scarrow G; Lam RW; Adam MJ; Zis AP; Ruth TJ
Arch Gen Psychiatry; 2000 Sep; 57(9):850-8. PubMed ID: 10986548
[TBL] [Abstract][Full Text] [Related]
8. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia.
Rasmussen H; Erritzoe D; Andersen R; Ebdrup BH; Aggernaes B; Oranje B; Kalbitzer J; Madsen J; Pinborg LH; Baaré W; Svarer C; Lublin H; Knudsen GM; Glenthoj B
Arch Gen Psychiatry; 2010 Jan; 67(1):9-16. PubMed ID: 20048218
[TBL] [Abstract][Full Text] [Related]
9. Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.
Lewis R; Kapur S; Jones C; DaSilva J; Brown GM; Wilson AA; Houle S; Zipursky RB
Am J Psychiatry; 1999 Jan; 156(1):72-8. PubMed ID: 9892300
[TBL] [Abstract][Full Text] [Related]
10. Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.
Trichard C; Paillère-Martinot ML; Attar-Levy D; Recassens C; Monnet F; Martinot JL
Am J Psychiatry; 1998 Apr; 155(4):505-8. PubMed ID: 9545996
[TBL] [Abstract][Full Text] [Related]
11. Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging.
Kapur S; Jones C; DaSilva J; Wilson A; Houle S
Nucl Med Commun; 1997 May; 18(5):395-9. PubMed ID: 9194079
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
Muguruza C; Moreno JL; Umali A; Callado LF; Meana JJ; González-Maeso J
Eur Neuropsychopharmacol; 2013 Aug; 23(8):852-64. PubMed ID: 23176747
[TBL] [Abstract][Full Text] [Related]
13. No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET.
Trichard C; Paillère-Martinot ML; Attar-Levy D; Blin J; Feline A; Martinot JL
Schizophr Res; 1998 May; 31(1):13-7. PubMed ID: 9633832
[TBL] [Abstract][Full Text] [Related]
14. Greater loss of 5-HT(2A) receptors in midlife than in late life.
Sheline YI; Mintun MA; Moerlein SM; Snyder AZ
Am J Psychiatry; 2002 Mar; 159(3):430-5. PubMed ID: 11870007
[TBL] [Abstract][Full Text] [Related]
15. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
[TBL] [Abstract][Full Text] [Related]
16. Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.
Simpson HB; Slifstein M; Bender J; Xu X; Hackett E; Maher MJ; Abi-Dargham A
Biol Psychiatry; 2011 Nov; 70(9):897-904. PubMed ID: 21855857
[TBL] [Abstract][Full Text] [Related]
17. Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophrenia.
Eastwood SL; Burnet PW; Gittins R; Baker K; Harrison PJ
Synapse; 2001 Nov; 42(2):104-14. PubMed ID: 11574947
[TBL] [Abstract][Full Text] [Related]
18. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography.
Mintun MA; Sheline YI; Moerlein SM; Vlassenko AG; Huang Y; Snyder AZ
Biol Psychiatry; 2004 Feb; 55(3):217-24. PubMed ID: 14744461
[TBL] [Abstract][Full Text] [Related]
19. Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET.
Santhosh L; Estok KM; Vogel RS; Tamagnan GD; Baldwin RM; Mitsis EM; Macavoy MG; Staley JK; van Dyck CH
Psychiatry Res; 2009 Sep; 173(3):212-7. PubMed ID: 19682865
[TBL] [Abstract][Full Text] [Related]
20. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
